Join
Live feed
·
INSIDERFilingvia Quantisnow
Lexaria Bioscience Corp. logo

Director Turkel Catherine C. bought $5,008 worth of shares (1,600 units at $3.13), increasing direct ownership by 107% to 3,100 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LEXX (Lexaria Bioscience Corp.) and more on Quantisnow.